Kiawah Island, SC, United States of America

Gene Zurlo




Average Co-Inventor Count = 3.0

ph-index = 2

Forward Citations = 29(Granted Patents)


Location History:

  • Kiawah Island, SC (US) (2011)
  • Kiwah Island, SC (US) (2012)

Company Filing History:


Years Active: 2011-2012

Loading Chart...
Loading Chart...
Loading Chart...
2 patents (USPTO):Explore Patents

Title: The Innovative Contributions of Gene Zurlo

Introduction

Gene Zurlo is a notable inventor based in Kiawah Island, SC (US). He has made significant contributions to the field of plasma technologies, particularly in the isolation and formulation of therapeutic products. With a total of two patents to his name, Zurlo's work has the potential to impact the medical community positively.

Latest Patents

Zurlo's latest patents include methods for achieving ultra-high yields of alpha-1-antitrypsin and a novel process for producing intravenous immune globulin. The first patent focuses on isolating alpha-1-antitrypsin from cryo-poor plasma using various salts, resulting in higher yields and superior quality. The second patent describes an alcohol-free plasma fractionation process that produces a high-yielding, non-denatured intravenous human immune gamma globulin (IgG) product.

Career Highlights

Zurlo's career is marked by his dedication to advancing plasma technology. His innovative methods have garnered attention for their effectiveness and efficiency in producing critical therapeutic products. His work at Plasma Technologies, LLC has positioned him as a key player in the field.

Collaborations

Zurlo collaborates with esteemed colleagues, including Dennis Curtin and Allan L Louderback. Their combined expertise enhances the development of groundbreaking technologies in plasma fractionation.

Conclusion

Gene Zurlo's contributions to plasma technology through his patents and collaborative efforts highlight his role as an influential inventor. His work continues to pave the way for advancements in therapeutic product formulation.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…